US-headquartered Goodwin has hired Colm Murphy as a partner in its London team in a bid to bolster the firm’s prosecution ...

With 2025 behind us, US practitioners sit down with Managing IP to discuss the major IP moments from the year and what to ...

Large-scale transatlantic mergers will give US entities a strong foothold at the UPC, and could spark further fragmentation ...

Hoglund, who announced yesterday, December 15, that he is to leave Via at the end of 2025, is set to reveal his new venture in the new year.

David Ives, Laura Houston, and Richard Barker of Slaughter and May examine the UK High Court’s ruling and assess its implications for AI developers, rights holders, and future appeals On November 4 ...

David is a partner in Slaughter and May’s technology, digital, data, and intellectual property (IP) group and is the firm’s head of IP. He advises on all aspects of IP protection, exploitation, and ...

Varuni Paranavitane of Finnegan and IP counsel Lisa Ribes compare and contrast two recent AI copyright decisions from Germany and the UK Recent Court decisions in the UK and Germany highlight ...

In this episode, sponsored by Zacco, we delve into Online IP Protection and how the concept of protecting brands online is evolving. Many of you will have heard of Online Brand Protection, a service ...

With the US privacy landscape more fragmented and active than ever and federal legislation stalled, lawyers at Sheppard Mullin explain how states are taking bold steps to define their own regimes By ...

National groups for the UK and the Netherlands have flagged concerns with the choice of venue, following a formal complaint from Australia’s national group Netherlands and UK-based members of the ...

The winner of a high-profile bidding war for Warner Bros Discovery may gain a strategic advantage far greater than mere subscriber growth - IP licensing leverage Warner Bros Discovery’s potential ...

Koen Bijvank of Brinkhof and Johannes Heselberger of Bardehle Pagenberg discuss the Amgen v Sanofi case and why it will be cited frequently Amgen successfully defended its European patent (EP ...